.Pharmacolibrary.Drugs.V_Various.V10A_AntiinflammatoryAgents.V10AX04_Erbium169erCitrateColloi.Erbium169erCitrateColloi .Pharmacolibrary.Drugs.V_Various.V10A_AntiinflammatoryAgents.V10AX04_Erbium169erCitrateColloi.Erbium169erCitrateColloi| name: | Erbium169erCitrateColloid | |
| ATC code: | V10AX04 | route: | intraarticular |
| compartments: | 1 | |
| dosage: | 30 | mg |
| volume of distribution: | 0.01 | L |
| clearance: | 0.001 | L/h |
| other parameters in model implementation | ||
Erbium-169 citrate colloid is a radiopharmaceutical used predominantly for the treatment of chronic synovitis by radiosynovectomy, especially in small joints affected by rheumatoid arthritis. It delivers localized beta radiation after intra-articular injection. Its use is limited to specific therapeutic procedures and it does not have broad regulatory approval for routine use.
No published human pharmacokinetic studies available; estimates based on related radiocolloid agents administered intra-articularly for synovectomy.